Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c82f1477b71e93f1ff6e9b27d67ec77 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
filingDate |
2021-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fb772d73f2fa5f9b0b4d43244776adb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95cf31fd42bb6ea0bc803bd9c139a01f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c34643ab7d7fa8e51b0c4c552cad4b11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31b2b2c9a48f92f71124504b23cf2e47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdf528361d83f41f575b333472e8f1b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb26b745fc367ef8a3273b412c7a82bc |
publicationDate |
2021-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2021253041-A1 |
titleOfInvention |
Naphthyridine derivatives useful as alk5 inhibitors |
abstract |
The present disclosure provides crystalline forms and salts of activin receptor-like kinase 5 (ALK5) inhibitors of Formula (I). Also disclosed are pharmaceutical compositions comprising the crystalline forms, methods of using the crystalline forms to modulate the activity of ALK5 and methods of treating disorders mediated by ALK5 using the crystalline forms. Formula (I) |
priorityDate |
2020-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |